Time Course of Antispike Antibody Titer after Administration of BNT162b2 mRNA COVID-19 Vaccine in a Patient with Rheumatoid Arthritis on Methotrexate

Methotrexate, an anchor drug for rheumatoid arthritis, hinders the immunogenicity of mRNA COVID-19 vaccines. Therefore, an optimal vaccine strategy for patients with rheumatoid arthritis receiving methotrexate is vital. We monitored antispike antibody titers after BNT162b2 mRNA COVID-19 vaccination...

Descripción completa

Detalles Bibliográficos
Autores principales: Shinohara, Satoshi, Hirose, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132894/
https://www.ncbi.nlm.nih.gov/pubmed/37124958
http://dx.doi.org/10.1155/2023/4525249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132894/
https://www.ncbi.nlm.nih.gov/pubmed/37124958
http://dx.doi.org/10.1155/2023/4525249

Ejemplares similares